Aymeric Bordet

Aymeric Bordet has held various CFO roles on a part-time basis since 2016. That year, they began acting as a DAF in PME and Start-ups across Paris, Lyon, Aix-Marseille, Bordeau, and San Francisco. In 2015, they became a Partner and Secretary General at Angelor, where they were responsible for finances, digitalization, legal matters, and portfolio evaluation. In 2017, they took on the role of Group CFO at Traefik Labs and CFO at DEEPLINK MEDICAL. In 2018, they became CFO at Mensia Technologies. In 2019, they took on the role of Group CFO at Agicap and CFO at Primo1D. In 2021, they became CFO at Brenus Pharma and TransCure bioServices.

Aymeric Bordet obtained a Master's degree in Business Administration and Management, General from SKEMA Business School in 2008 and a Master's degree in Master CCA Accountancy Audit Control from University of Lille 1 Sciences and Technology in 2008.